l carnitine and liver disease Impact of l-Carnitine Supplementation on Enzyme Normalization in Patients with Chronic Liver Disease: A Meta-Analysis of Randomized Trials Didn't another study show carnitine

Biomarkers for alzheimers disease Given the failure of amyloid plaque clearance drugs, and the likelihood that the current focus on tau aggregation inhibitors will also yield disappointing results, new therapeutic approaches are clearly needed to alter clinical outcome for Alzheimers patients

Localization of canine, feline, and mouse renal membrane proteins

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM

Their roles extend beyond neuronal development and synaptic formation to include contributions to disease progression and aging

It also supports liver function